About Vibonum
We are a pharmaceutical company focused on developing, out-licensing, manufacturing and supplying high value branded and select complex generic medicines.
We pioneer innovative value added combinations fostering benefits throughout the value chain resulting in benefits for our partners, payers, prescribers and patients particularly in heart disease, diabetes and obesity management.
Key Facts
1M+
patients taking our cardiovascular medicines every day
40+
Patents – Granted, Filed or under development
2,3
Products in market and New products currently under registration
4M
patients supply capacity being built at new manufacturing sites
13
additional products to be filed in next 12-18 months
40
countries where our products are approved
23
products in current pipeline
60%
Volume growth expected in 2026 vs 2025
Manufacturing Units
Explore our licensed manufacturing units and their key compliance, quality, and operational capabilities.
Key Facts
Vibonum Technologies Pvt. Ltd. - Unit-I
Approved small-scale manufacturing unit with state-of-the-art QC lab for stability and pilot studies.
Key Facts
Vibonum Technologies Pvt. Ltd. - Unit-II
EU GMP-aligned solid oral dosage facility in Nanjangud Industrial Area, Karnataka.